SAIPARENT quarterly results and annual financials: sales, operating profit, OPM, net profit, EPS, balance sheet, cash flow and ratios like ROCE, with YoY and QoQ growth.
Sai Parenterals Ltd reported sales of ₹178.67 Cr, operating profit of ₹23.52 Cr (OPM 13.16%) and net profit of ₹7.92 Cr for the quarter ended Jun 2026. Figures in ₹ crore, consolidated where available.
SAIPARENT quarterly results (₹ Cr)
Metric
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sales
33.39
87
96.15
197.93
178.67
Expenses
28.65
71
99.71
171.83
155.15
Operating Profit
4.74
16
-3.56
26.1
23.52
OPM
14.2%
19%
-3.7%
13.19%
13.16%
Other Income
1.17
3
3.13
2.88
3.74
Interest
2.46
5
5.41
8.4
9.36
Depreciation
1.45
3
5.79
8.18
8.11
Profit before tax
2
11
-11.63
12.4
9.79
Tax
29.5%
30%
-42.65%
-6.13%
19%
Net Profit
1.42
8
-6.66
13.16
7.92
EPS in Rs
0.52
2.11
-1.8
2.98
1.79
SAIPARENT profit & loss, annual (₹ Cr)
Metric
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
97
154
163
381
Expenses
78
122
124
342
Operating Profit
19
32
39
39
OPM
19%
21%
24%
10%
Other Income
0
1
1
9
Interest
6
11
12
19
Depreciation
6
9
8
17
Profit before tax
7
13
20
12
Tax
40%
33%
28%
-20%
Net Profit
4
8
14
14
EPS in Rs
3.06
3.18
5.43
3.23
Dividend Payout
0%
0%
0%
0%
SAIPARENT balance sheet (₹ Cr)
Metric
Mar 2023
Mar 2024
Mar 2025
Sep 2025
Mar 2026
Equity Capital
7
13
13
18
22
Reserves
24
61
80
189
469
Borrowings
69
119
94
78
469
Other Liabilities
34
75
85
91
465
Total Liabilities
134
268
272
376
1,424
Fixed Assets
44
70
53
55
364
CWIP
2
0
0
2
212
Investments
0
0
0
0
0
Other Assets
88
198
219
320
848
Total Assets
134
268
272
376
1,424
SAIPARENT cash flows (₹ Cr)
Metric
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Cash from Operating Activity
-13
-30
33
93
Cash from Investing Activity
-19
-46
0
-274
Cash from Financing Activity
24
79
-36
596
Net Cash Flow
-8
2
-2
415
Free Cash Flow
-30
-72
41
-184
CFO/OP
-54%
-94%
86%
253%
CFO/EBITDAShare of operating profit converting into cash: CFO (before tax) / Operating Profit